rs61751507

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001308.3(CPN1):​c.533G>A​(p.Gly178Asp) variant causes a missense change. The variant allele was found at a frequency of 0.043 in 1,613,682 control chromosomes in the GnomAD database, including 1,667 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.035 ( 131 hom., cov: 31)
Exomes 𝑓: 0.044 ( 1536 hom. )

Consequence

CPN1
NM_001308.3 missense

Scores

1
7
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1B:4

Conservation

PhyloP100: 6.17

Publications

29 publications found
Variant links:
Genes affected
CPN1 (HGNC:2312): (carboxypeptidase N subunit 1) Carboxypeptidase N is a plasma metallo-protease that cleaves basic amino acids from the C terminal of peptides and proteins. The enzyme is important in the regulation of peptides like kinins and anaphylatoxins, and has also been known as kininase-1 and anaphylatoxin inactivator. This enzyme is a tetramer comprised of two identical regulatory subunits and two identical catalytic subunits; this gene encodes the catalytic subunit. Mutations in this gene can be associated with angioedema or chronic urticaria resulting from carboxypeptidase N deficiency. [provided by RefSeq, Jul 2008]
CPN1 Gene-Disease associations (from GenCC):
  • carboxypeptidase N deficiency
    Inheritance: AR Classification: LIMITED Submitted by: Illumina, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0053716004).
BP6
Variant 10-100069757-C-T is Benign according to our data. Variant chr10-100069757-C-T is described in ClinVar as Benign. ClinVar VariationId is 6623.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0682 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001308.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPN1
NM_001308.3
MANE Select
c.533G>Ap.Gly178Asp
missense
Exon 3 of 9NP_001299.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPN1
ENST00000370418.8
TSL:1 MANE Select
c.533G>Ap.Gly178Asp
missense
Exon 3 of 9ENSP00000359446.3

Frequencies

GnomAD3 genomes
AF:
0.0346
AC:
5254
AN:
151744
Hom.:
131
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00899
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0525
Gnomad ASJ
AF:
0.0245
Gnomad EAS
AF:
0.0242
Gnomad SAS
AF:
0.0297
Gnomad FIN
AF:
0.0344
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0479
Gnomad OTH
AF:
0.0456
GnomAD2 exomes
AF:
0.0423
AC:
10647
AN:
251480
AF XY:
0.0420
show subpopulations
Gnomad AFR exome
AF:
0.00910
Gnomad AMR exome
AF:
0.0669
Gnomad ASJ exome
AF:
0.0250
Gnomad EAS exome
AF:
0.0243
Gnomad FIN exome
AF:
0.0400
Gnomad NFE exome
AF:
0.0492
Gnomad OTH exome
AF:
0.0450
GnomAD4 exome
AF:
0.0438
AC:
64060
AN:
1461822
Hom.:
1536
Cov.:
32
AF XY:
0.0437
AC XY:
31788
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.00824
AC:
276
AN:
33480
American (AMR)
AF:
0.0632
AC:
2825
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0266
AC:
694
AN:
26136
East Asian (EAS)
AF:
0.0245
AC:
971
AN:
39698
South Asian (SAS)
AF:
0.0250
AC:
2159
AN:
86258
European-Finnish (FIN)
AF:
0.0392
AC:
2095
AN:
53420
Middle Eastern (MID)
AF:
0.0740
AC:
427
AN:
5768
European-Non Finnish (NFE)
AF:
0.0470
AC:
52277
AN:
1111948
Other (OTH)
AF:
0.0387
AC:
2336
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
3315
6630
9945
13260
16575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1900
3800
5700
7600
9500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0346
AC:
5255
AN:
151860
Hom.:
131
Cov.:
31
AF XY:
0.0335
AC XY:
2483
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.00894
AC:
370
AN:
41404
American (AMR)
AF:
0.0525
AC:
799
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
0.0245
AC:
85
AN:
3470
East Asian (EAS)
AF:
0.0242
AC:
125
AN:
5160
South Asian (SAS)
AF:
0.0299
AC:
143
AN:
4784
European-Finnish (FIN)
AF:
0.0344
AC:
363
AN:
10564
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0479
AC:
3254
AN:
67960
Other (OTH)
AF:
0.0452
AC:
95
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
245
490
735
980
1225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0436
Hom.:
257
Bravo
AF:
0.0353
TwinsUK
AF:
0.0464
AC:
172
ALSPAC
AF:
0.0428
AC:
165
ESP6500AA
AF:
0.0109
AC:
48
ESP6500EA
AF:
0.0480
AC:
413
ExAC
AF:
0.0418
AC:
5076
Asia WGS
AF:
0.0200
AC:
70
AN:
3478
EpiCase
AF:
0.0546
EpiControl
AF:
0.0552

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Anaphylotoxin inactivator deficiency Pathogenic:1Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 01, 2003
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all):461/13006=3.54%

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

CPN1-related disorder Benign:1
Jul 08, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.34
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.41
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.39
T
Eigen
Benign
0.16
Eigen_PC
Benign
0.11
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.94
D
MetaRNN
Benign
0.0054
T
MetaSVM
Benign
-1.2
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
6.2
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-4.2
D
REVEL
Uncertain
0.32
Sift
Benign
0.17
T
Sift4G
Benign
0.33
T
Polyphen
0.86
P
Vest4
0.29
MPC
1.3
ClinPred
0.055
T
GERP RS
4.3
Varity_R
0.54
gMVP
0.94
Mutation Taster
=76/24
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61751507; hg19: chr10-101829514; COSMIC: COSV107465314; COSMIC: COSV107465314; API